MARIA CATERINA ROTIROTI

Postdoctoral Scholar, Hematology-Oncology

Honors & Awards

Postdoctoral Fellowship, Maternal & Child Health Research Institute (MCHRI) (2021-2022)
Postdoctoral Fellowship, American Italian Cancer Foundation (AICF) (2020-2021)
Beat Leukemia Fellowship, Societa' Italiana di Ematologia Sperimentale (SIES) (2018 –2019)
PhD Fellowship, Translational and Molecular Medicine program, University of Milano-Bicocca, Italy (2015-2018)
Post-graduate Fellowship, “M. Tettamanti” Research Center, Monza, Italy (2015)

Professional Education

PhD, University of Milano-Bicocca Milano, Italy, Translational and Molecular Medicine (2019)
MS, University of Milano-Bicocca Milano, Italy, Medical Biotechnology (2015)
BS, Magna Graecia University, Catanzaro, Italy, Biotechnology (2012)

All Publications

Profiles With Related Publications

close
Tatjana Bilich

Postdoctoral Scholar, Immunity Transplant Infection

14 Total Publications
close
Axel Brunger

Professor of Molecular and Cellular Physiology, of Neurology, of Photon Science and, by courtesy, of Structural Biology
Research Interests
One of Axel Brunger's major goals is to decipher the molecular mechanisms of synaptic neurotransmitter release by conducting imaging and single-molecule/particle reconstitution experiments, combined with near-atomic resolution structural studies of the synaptic vesicle fusion machinery.

167 Total Publications
close
Yueh-hsiu Chien

Professor of Microbiology & Immunology
Research Interests
Contribution of T cells to immunocompetence and autoimmunity; how the immune system clears infection, avoids autoimmunity and how infection impacts on the development of immune responses.

103 Total Publications
close
Camilo Espinosa

Ph.D. Student in Immunology, admitted Autumn 2019 Masters Student in Computer Science, admitted Autumn 2021

4 Total Publications
close
C. Garrison Fathman

Professor of Medicine (Immunology and Rheumatology), Emeritus
Research Interests
My lab of molecular and cellular immunology is interested in research in the general field of T cell activation and autoimmunity. We have identified and characterized a gene (GRAIL) that seems to control regulatory T cell (Treg) responsiveness by inhibiting the Treg IL-2 receptor desensitization. We have characterized a gene (Deaf1) that plays a major role in peripheral tolerance in T1D. Using PBC gene expression, we have provisionally identified a signature of risk and progression in T1D.

324 Total Publications
close
Chris Garcia

Younger Family Professor and Professor of Structural Biology
Research Interests
Structural and functional studies of transmembrane receptor interactions with their ligands in systems relevant to human health and disease - primarily in immunity, infection, and neurobiology. We study these problems using protein engineering, structural, biochemical, and combinatorial biology approaches.

245 Total Publications
close
Jorg Goronzy

Professor of Medicine (Immunology and Rheumatology), Emeritus

459 Total Publications
close
Lauren Higdon

Instructor, Medicine - Nephrology

19 Total Publications
close
Nikolaus Jahn

Postdoctoral Scholar, Pathology

9 Total Publications
close
Ted Jardetzky

Professor of Structural Biology
Research Interests
The Jardetzky laboratory is studying the structures and mechanisms of macromolecular complexes important in viral pathogenesis, allergic hypersensitivities and the regulation of cellular growth and differentiation, with an interest in uncovering novel conceptual approaches to intervening in disease processes. Ongoing research projects include studies of paramyxovirus and herpesvirus entry mechanisms, IgE-receptor structure and function and TGF-beta ligand signaling pathways.

185 Total Publications
close
Thomas Koehnke

Postdoctoral Scholar, Stanford Cancer Center

26 Total Publications
close
Crystal Mackall

Ernest and Amelia Gallo Family Professor and Professor of Pediatrics and of Medicine
Clinical Focus
Pediatric Hematology-Oncology
Research Interests
Recent clinical studies, by us and others, have demonstrated that genetically engineered T cells can eradicate cancers resistant to all other therapies. We are identifying new targets for these therapeutics, exploring pathways of resistance to current cell therapies and creating next generation platforms to overcome therapeutic resistance. We have discovered novel insights into the biology of human T cell exhaustion and developed approaches to prevent and reverse this phenomenon.

309 Total Publications